Another day, another $100M-plus biotech megaround as radiopharmaceuticals’ popularity grows
After getting started in 2017 with a $25 million launch round, Fusion Pharmaceuticals has bagged a $105 million mega round to advance their work …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
